An Observational Study of Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) Who Switched IOP-lowering Treatments

NCT01735214 · clinicaltrials.gov ↗

COMPLETED

Status

358

Enrollment

INDUSTRY

Sponsor class

Conditions

Glaucoma, Open-Angle
Ocular Hypertension

Interventions

DRUG: Prostaglandin Analogue -Containing IOP-Lowering Therapy

Sponsor

Allergan